| oncogenic RET and loss of p18 cooperate in the multistep tumorigenesis of medullary thyroid carcinoma | thyroid, |
| RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer. | thyroid, |
| The majority of medullary thyroid cancers are sporadic, but 20% of cases are a result of a germline mutation in the ret proto-oncogene. | thyroid, |
| New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. | thyroid, |
| Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene. | thyroid, |
| Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma. | thyroid, |
| When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?. | thyroid, |
| Stromal Tenascin-C expression seems to be an indicator of a further step in carcinogenesis of medullary thyroid carcinoma irrespective of a RET oncogene germ-line mutation. | thyroid, |
| Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia. | thyroid, |
| study showed RET/PTC rearrangements occur in a small population of tumor cells in papillary thyroid carcinomas; results suggest possibility of RET/PTC as passenger abnormalities rather than driver oncogenic mutation during thyroid cancer progression | thyroid, |
| Cx32, which negatively controls thyroid growth activated by thyrotropin via the cAMP pathway, would act as a positive effector of thyroid growth triggered by oncogenes acting through other signaling cascades. | thyroid, |
| Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland. | thyroid, |
| High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells. | thyroid, |
| Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy. | neoplasm,thyroid, |
| Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity. | thyroid, |
| One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?. | PCPG,thyroid, |
| Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. | neuroblastoma,leukemia, |
| DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. | thyroid, |
| c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines. | skin, |
| Familial nonmultiple endocrine neoplasia medullary thyroid cancer in 4 sisters, all having RET proto-oncogene polymorphism in exon 15 and 2 having additional polymorphism in exon 13 is reported. | thyroid, |